WAT

SELL

Waters Corporation

Healthcare · Rank #247 · Analyzed Jul 13, 2026

$376.43

Current Price

$81.39

Intrinsic Value

-78.4%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 78.4%

Fair Value Range

Low$40.69

Base (IV)$81.39

High$105.80

Entry Points

Conservative$28.48

Moderate$40.69

Aggressive$56.97

Quality & Moat Breakdown

Return on Equity5.2% → 0/1.0

Debt LevelD/E 37 → 0.5/1.0

Revenue QualityGrowth 7.1%, margin Δ-0.6% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins11.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.